Drusen as risk factors in age-related macular disease.

PubWeight™: 1.66‹?› | Rank: Top 3%

🔗 View Article (PMID 1688685)

Published in Am J Ophthalmol on January 15, 1990

Authors

D Pauleikhoff1, M J Barondes, D Minassian, I H Chisholm, A C Bird

Author Affiliations

1: Department of Clinical Ophthalmology, Institute of Ophthalmology, London, England.

Articles citing this

Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography. Ophthalmology (2009) 2.07

Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography. Ophthalmology (2011) 1.96

Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 1.85

Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am J Pathol (2003) 1.85

CNV subtype in first eyes predicts severity of ARM in fellow eyes. Br J Ophthalmol (2003) 1.44

Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol (2001) 1.37

Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography. Ophthalmology (2013) 1.35

Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration. Autophagy (2013) 1.34

Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28. Ophthalmology (2010) 1.32

Bruch's membrane change with age. Br J Ophthalmol (1992) 1.19

Changes in fundus autofluorescence in patients with age-related maculopathy. Correlation to visual function: a prospective study. Graefes Arch Clin Exp Ophthalmol (2004) 1.17

Age-related changes in human macular Bruch's membrane as seen by quick-freeze/deep-etch. Exp Eye Res (2007) 1.14

Viewing ageing eyes: diverse sites of amyloid Beta accumulation in the ageing mouse retina and the up-regulation of macrophages. PLoS One (2010) 1.10

The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit. Br J Ophthalmol (2000) 0.99

Age-related Bruch's membrane change: a clinical study of the relative role of heredity and environment. Br J Ophthalmol (1993) 0.96

Cone-mediated multifocal electroretinogram in age-related macular degeneration: progression over a long-term follow-up. Arch Ophthalmol (2006) 0.92

Insights into pathology of cuticular drusen from integrated confocal scanning laser ophthalmoscopy imaging and corresponding spectral domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol (2011) 0.89

Age-related macular degeneration and changes in the extracellular matrix. Med Sci Monit (2014) 0.88

Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol (2004) 0.86

Change in drusen area over time compared using spectral-domain optical coherence tomography and color fundus imaging. Invest Ophthalmol Vis Sci (2014) 0.85

Combining macula clinical signs and patient characteristics for age-related macular degeneration diagnosis: a machine learning approach. BMC Ophthalmol (2015) 0.83

Basement membranes and artificial substrates in cell transplantation. Graefes Arch Clin Exp Ophthalmol (2003) 0.83

Drusen and Pro-inflammatory Mediators in the Post-Mortem Human Eye. J Clin Exp Ophthalmol (2012) 0.83

Age-related macular degeneration. Postgrad Med J (1998) 0.83

Comparison of drusen area detected by spectral domain optical coherence tomography and color fundus imaging. Invest Ophthalmol Vis Sci (2013) 0.82

Topographical control of ocular cell types for tissue engineering. J Biomed Mater Res B Appl Biomater (2013) 0.82

Cone structure in subjects with known genetic relative risk for AMD. Optom Vis Sci (2014) 0.78

Correlations between Photodegradation of Bisretinoid Constituents of Retina and Dicarbonyl Adduct Deposition. J Biol Chem (2015) 0.78

Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease. Mol Psychiatry (2017) 0.76

Dynamic Drusen Remodelling in Participants of the Nutritional AMD Treatment-2 (NAT-2) Randomized Trial. PLoS One (2016) 0.76

Quantification of fluorescein-stained drusen associated with age-related macular degeneration. Retina (2012) 0.76

Multimodal morphological and functional characterization of Malattia Leventinese. Graefes Arch Clin Exp Ophthalmol (2012) 0.76

[Seasonal fluctuations and influence of nutrition on macular pigment density]. Ophthalmologe (2006) 0.75

Treatment of age-related subfoveal neovascular membranes by teletherapy. Br J Ophthalmol (1993) 0.75

Choroidal neovascularisation in age-related macular disease. Br J Ophthalmol (1993) 0.75

Clinically detectable drusen domains in fibulin-5-associated age-related macular degeneration (AMD) : Drusen subdomains in fibulin-5 AMD. Int Ophthalmol (2015) 0.75

Early deterioration in ellipsoid zone in eyes with non-neovascular age-related macular degeneration. Int Ophthalmol (2016) 0.75

Polypoidal choroidal vasculopathy with drusen. Jpn J Ophthalmol (2008) 0.75

Indocyanine green angiographic findings in fellow eyes of patients with unilateral occult neovascular age-related macular degeneration. Int Ophthalmol (1997) 0.75

Scaffolds for retinal pigment epithelial cell transplantation in age-related macular degeneration. J Tissue Eng (2017) 0.75

Articles by these authors

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol (1995) 10.05

National survey of blindness and low vision in The Gambia: results. Br J Ophthalmol (1989) 6.38

Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol (1995) 3.62

A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet (1999) 3.32

Reduction of trachoma in a sub-Saharan village in absence of a disease control programme. Lancet (1997) 3.21

X-linked retinitis pigmentosa. Br J Ophthalmol (1975) 3.11

Tears of detached retinal pigment epithelium. Br J Ophthalmol (1981) 3.08

A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11). Mol Cell (2001) 3.07

Contact lenses and other risk factors in microbial keratitis. Lancet (1991) 3.04

A new locus for autosomal dominant retinitis pigmentosa on chromosome 7p. Nat Genet (1993) 2.97

Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nat Genet (2000) 2.82

Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol (2006) 2.67

Close genetic linkage between X-linked retinitis pigmentosa and a restriction fragment length polymorphism identified by recombinant DNA probe L1.28. Nature (1984) 2.52

Mutations in the pre-mRNA splicing factor gene PRPC8 in autosomal dominant retinitis pigmentosa (RP13). Hum Mol Genet (2001) 2.48

RPGR mutation associated with retinitis pigmentosa, impaired hearing, and sinorespiratory infections. J Med Genet (2003) 2.45

Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci (1997) 2.31

Rapid serological test for diagnosis of chlamydial ocular infections. Br J Ophthalmol (1978) 2.25

The development of neovascularization of senile disciform macular degeneration. Am J Ophthalmol (1973) 2.17

Recent advances in the treatment of senile disciform macular degeneration by photocoagulation. Br J Ophthalmol (1974) 2.14

In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol (1997) 2.10

Senile disciform macular degeneration in the second eye. Br J Ophthalmol (1977) 2.07

Bilateral acute retinal necrosis. Br J Ophthalmol (1978) 2.07

Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol (2001) 2.04

Aging changes in Bruch's membrane. A histochemical and morphologic study. Ophthalmology (1990) 1.99

Escherichia coli O157 and Salmonella infections associated with sprouts in California, 1996-1998. Ann Intern Med (2001) 1.96

Outcome of cataract surgery in central India: a longitudinal follow-up study. Br J Ophthalmol (1991) 1.91

Measuring the burden of childhood blindness. Br J Ophthalmol (1999) 1.91

Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol (1988) 1.90

A 3-bp deletion in the rhodopsin gene in a family with autosomal dominant retinitis pigmentosa. Am J Hum Genet (1991) 1.88

A clinical, psychophysical, and electroretinographic survey of patients with autosomal dominant retinitis pigmentosa. Br J Ophthalmol (1985) 1.87

Mutations in the retinal guanylate cyclase (RETGC-1) gene in dominant cone-rod dystrophy. Hum Mol Genet (1998) 1.84

A mutation in guanylate cyclase activator 1A (GUCA1A) in an autosomal dominant cone dystrophy pedigree mapping to a new locus on chromosome 6p21.1. Hum Mol Genet (1998) 1.81

A completed screen for mutations of the rhodopsin gene in a panel of patients with autosomal dominant retinitis pigmentosa. Hum Mol Genet (1992) 1.80

A mutation in NRL is associated with autosomal dominant retinitis pigmentosa. Nat Genet (1999) 1.79

A clinical study of the vascularity of senile disciform macular degeneration. Am J Ophthalmol (1973) 1.77

Degenerative changes in a retina affected with autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci (1989) 1.75

Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol (1985) 1.74

Functional characterisation and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Br J Ophthalmol (2006) 1.74

Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol (2002) 1.74

Vascular tufts at the pupillary margin in myotonic dystrophy. Am J Ophthalmol (1970) 1.71

Identification of a sixth locus for autosomal dominant retinitis pigmentosa on chromosome 19. Hum Mol Genet (1994) 1.71

Acute zonal occult outer retinopathy: towards a set of diagnostic criteria. Br J Ophthalmol (2005) 1.70

Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci (1992) 1.69

Choroidal perfusion abnormality with age-related Bruch's membrane change. Am J Ophthalmol (1990) 1.66

Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain (1987) 1.66

Autosomal dominant exudative vitreoretinopathy. Br J Ophthalmol (1980) 1.65

Retinal macroaneurysms. Br J Ophthalmol (1975) 1.64

Retinopathy in haemoglobin C trait. Eye (Lond) (1996) 1.63

The role of axoplasmic transport in the pathogenesis of retinal cotton-wool spots. Br J Ophthalmol (1977) 1.62

Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab (1997) 1.58

Vitamin A treatment for night blindness in primary biliary cirrhosis. Br Med J (Clin Res Ed) (1984) 1.57

Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol (1994) 1.55

Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain (1987) 1.54

Incidence of aphakic macular oedema. A prospective study. Br J Ophthalmol (1975) 1.54

Senile disciform macular degeneration: features indicating suitability for photocoagulation. Br J Ophthalmol (1979) 1.54

Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. Br J Ophthalmol (1993) 1.51

On the retinal vasculature of the human fovea. Exp Eye Res (1974) 1.50

Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology (1994) 1.49

Low vision services for vision rehabilitation in the United Kingdom. Br J Ophthalmol (2002) 1.47

Autosomal dominant retinitis pigmentosa: four new mutations in rhodopsin, one of them in the retinal attachment site. Genomics (1991) 1.46

Long-term management of abetalipoproteinaemia. Possible role for vitamin E. Arch Dis Child (1977) 1.44

Histopathology of ruby and argon laser lesions in monkey and human retina. A comparative study. Br J Ophthalmol (1975) 1.42

Histopathology of incipient fundus flavimaculatus. Ophthalmology (1991) 1.42

Radiotherapy for age-related macular degeneration. Clin Oncol (R Coll Radiol) (1998) 1.41

Autosomal dominant retinitis pigmentosa with apparent incomplete penetrance: a clinical, electrophysiological, psychophysical, and molecular genetic study. Br J Ophthalmol (1993) 1.41

A comparative histopathological study of argon and krypton laser irradiations of the human retina. Br J Ophthalmol (1979) 1.41

Functional correlates of fundus autofluorescence abnormalities in patients with RPGR or RIMS1 mutations causing cone or cone rod dystrophy. Br J Ophthalmol (2007) 1.40

The role of molecular genetics in the prenatal diagnosis of retinal dystrophies. Eye (Lond) (1995) 1.39

A linkage survey of 20 dominant retinitis pigmentosa families: frequencies of the nine known loci and evidence for further heterogeneity. J Med Genet (1998) 1.39

Sorsby's fundus dystrophy. A light and electron microscopic study. Ophthalmology (1989) 1.38

Outcome of psychotherapy among early adolescents after trauma. Am J Psychiatry (1997) 1.38

Experimental retinal branch vein occlusion in rhesus monkeys. I. Clinical appearances. Br J Ophthalmol (1979) 1.37

Risk factors for microbial keratitis with contemporary contact lenses: a case-control study. Ophthalmology (2008) 1.36

Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol (1998) 1.35

Visual prognosis of disciform degeneration in myopia. Ophthalmology (1983) 1.34

Distribution of pigment epithelium autofluorescence in retinal disease state recorded in vivo and its change over time. Graefes Arch Clin Exp Ophthalmol (1999) 1.34

Anterior chamber flare after trabeculectomy and after phacoemulsification. Br J Ophthalmol (2000) 1.33

Visual outcome following posterior capsule rupture during cataract surgery. Br J Ophthalmol (2001) 1.33

Confocal imaging of the fundus using a scanning laser ophthalmoscope. Br J Ophthalmol (1992) 1.32

Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study Group. Br J Ophthalmol (1999) 1.32

A fluorescein and indocyanine green angiographic study of choriocapillaris in age-related macular disease. Arch Ophthalmol (1999) 1.31

Sorsby's fundus dystrophy. A clinical study. Ophthalmology (1989) 1.30

Quantitative evaluation of fundus autofluorescence imaged "in vivo" in eyes with retinal disease. Br J Ophthalmol (2000) 1.29

Correlation between lipids extracted from Bruch's membrane and age. Ophthalmology (1993) 1.29

Acute zonal occult outer retinopathy (AZOOR) associated with multifocal choroidopathy. Eye (Lond) (1994) 1.29

Mutations in the RP2 gene cause disease in 10% of families with familial X-linked retinitis pigmentosa assessed in this study. Am J Hum Genet (1999) 1.28

Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments. Br J Ophthalmol (2000) 1.27

Ocular abnormalities in Alagille syndrome. Ophthalmology (1999) 1.25

Sickle cell retinopathy in Jamaican children: further observations from a cohort study. Br J Ophthalmol (1988) 1.25

X-linked recessive fundus dystrophies and their carrier states. Trans Ophthalmol Soc U K (1970) 1.25

Clinical characterisation of a family with retinal dystrophy caused by mutation in the Mertk gene. Br J Ophthalmol (2006) 1.24

Sickle cell retinopathy in young children in Jamaica. Br J Ophthalmol (1982) 1.24

Morphology of posterior segment lesions of the eye in patients with onchocerciasis. Br J Ophthalmol (1976) 1.24

Autosomal dominant cone-rod dystrophy with mutations in the guanylate cyclase 2D gene encoding retinal guanylate cyclase-1. Arch Ophthalmol (2001) 1.24